Sunshine Biopharma, Inc. (SBFM)
1.18
+0.01
(+0.85%)
USD |
NASDAQ |
Feb 20, 16:00
1.15
-0.03
(-2.54%)
Pre-Market: 20:00
Sunshine Biopharma Profit Margin (Quarterly) : -9.38% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 25.76% |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
| Savara, Inc. | -- |
| BioMarin Pharmaceutical, Inc. | -3.91% |
| Imunon, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -24.74% |
| Return on Assets | -19.55% |
| Return on Invested Capital | -23.90% |
| Gross Profit Margin (Quarterly) | 31.62% |
| Operating Margin (Quarterly) | -5.65% |
| Return on Net Operating Assets | -29.04% |